To print
:
Click here
or
Select
File
and then
Print
from your browser's menu
Singapore eDevelopment conducts clinical trials on Global BioLife’s Laetose
Singapore
SGX-listed Singapore eDevelopment Ltd recently announced the results of the clinical trials it conducted on Laetose, a low-glycaemic, naturally-modified sugar, developed by its US biomedical subsidiary Global BioLife, Inc.